Abstract
Aneurysms of the vascular wall represent a final common pathway for a number of inflammatory processes, including atherosclerosis and idiopathic vasculitis syndromes. Kawasaki disease (KD) is an acute, self-limited vasculitis in children and the leading cause of acquired coronary artery aneurysms. We sought to identify shared molecular mechanisms of aneurysm formation by genotyping eight polymorphisms in matrix metalloproteinase (MMP)-1, 3, 7, 12 and 13 in the gene cluster on Chr.11q22, whose gene products have been implicated in aneurysm formation or are known to have elastase activity. We genotyped 482 US–UK KD patients (aneurysm+: n=111, aneurysm−: n=371) and tested our findings in an independent cohort of 200 Japanese KD patients (aneurysm+: n=58, aneurysm−: n=142). Analysis of the five MMP genes identified modest trends in allele and genotype frequencies for MMP-3 rs3025058 (−/T) and haplotypes containing MMP-3 rs3025058 (−/T) and MMP-12 rs2276109 (A/G) (nominal P=2 to 4 × 10−5) that conferred increased risk of aneurysm formation in US–UK subjects. This finding was validated in Japanese subjects and suggests the importance of this locus in aneurysm formation in children with KD. The region encompassing these risk haplotypes is a prime candidate for resequencing to look for rare genetic variation that may influence aneurysm formation.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Takahashi, K., Oharaseki, T., Naoe, S., Wakayama, M. & Yokouchi, Y. Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease. Pediatr Int. 47, 305–310 (2005).
Inamo, Y., Harada, K., Okuni, M., Kimoto, K., Takeuchi, S. & Sakurabayashi, I. Immunoreactive polymorphonuclear leukocyte elastase in complex with alpha 1-antitrypsin in Kawasaki disease. Acta Paediatr Jpn. 29, 202–205 (1987).
Biezeveld, M. H., van Mierlo, G., Lutter, R., Kuipers, I. M., Dekker, T., Hack, C. E. et al. Sustained activation of neutrophils in the course of Kawasaki disease: an association with matrix metalloproteinases. Clin Exp Immunol. 141, 183–188 (2005).
Shapiro, S. D. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol. 10, 602–608 (1998).
Manicone, A. M. & McGuire, J. K. Matrix metalloproteinases as modulators of inflammation. Semin Cell Dev Biol. 19, 34–41 (2008).
Burns, J. C. & Glode, M. P. Kawasaki syndrome. Lancet. 364, 533–544 (2004).
Burgner, D., Davila, S., Breunis, W. B., Ng, S. B., Li, Y., Bonnard, C. et al. A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS genetics. 5, e1000319 (2009).
Burns, J. C., Shimizu, C., Gonzalez, E., Kulkarni, H., Patel, S., Shike, H. et al. Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease. J Infect Dis. 192, 344–349 (2005).
Burns, J. C., Shimizu, C., Shike, H., Newburger, J. W., Sundel, R. P., Baker, A. L. et al. Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease. Genes Immun. 6, 438–444 (2005).
Onouchi, Y., Gunji, T., Burns, J. C., Shimizu, C., Newburger, J. W., Yashiro, M. et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet. 40, 35–42 (2008).
Onouchi, Y., Tamari, M., Takahashi, A., Tsunoda, T., Yashiro, M., Nakamura, Y. et al. A genomewide linkage analysis of Kawasaki disease: evidence for linkage to chromosome 12. J Hum Genet. 52, 179–190 (2007).
Aziz, F. & Kuivaniemi, H. Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysm. Ann Vasc Surg. 21, 392–401 (2007).
Thompson, R. W. & Parks, W. C. Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann NY Acad Sci. 800, 157–174 (1996).
Newburger, J. W., Takahashi, M., Gerber, M. A., Gewitz, M. H., Tani, L. Y., Burns, J. C. et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 110, 2747–2771 (2004).
Disease, R.C.o.K. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease (Ministry of Health and Welfare, Tokyo, Japan, 1984).
Jormsjo, S., Whatling, C., Walter, D. H., Zeiher, A. M., Hamsten, A. & Eriksson, P. Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients. Arterioscler Thromb Vasc Biol. 21, 1834–1839 (2001).
Jormsjo, S., Ye, S., Moritz, J., Walter, D. H., Dimmeler, S., Zeiher, A. M. et al. Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease. Circ Res. 86, 998–1003 (2000).
Rutter, J. L., Mitchell, T. I., Buttice, G., Meyers, J., Gusella, J. F., Ozelius, L. J. et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res. 58, 5321–5325 (1998).
Ye, S., Eriksson, P., Hamsten, A., Kurkinen, M., Humphries, S. E. & Henney, A. M. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem. 271, 13055–13060 (1996).
Yoon, S., Kuivaniemi, H., Gatalica, Z., Olson, J. M., Buttice, G., Ye, S. et al. MMP13 promoter polymorphism is associated with atherosclerosis in the abdominal aorta of young black males. Matrix Biol. 21, 487–498 (2002).
Haq, I., Chappell, S., Johnson, S. R., Lotya, J., Daly, L., Morgan, K. et al. Association of MMP-2 polymorphisms with severe and very severe COPD: a case control study of MMPs-1, 9 and 12 in a European population. BMC Medical Genetics. 11, 7.
Joos, L., He, J. Q., Shepherdson, M. B., Connett, J. E., Anthonisen, N. R., Pare, P. D. et al. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum. Mol Genetics. 11, 569–576 (2002).
Ricketts, C., Zeegers, M. P., Lubinski, J. & Maher, E. R. Analysis of germline variants in CDH1, IGFBP3, MMP1, MMP3, STK15 and VEGF in familial and sporadic renal cell carcinoma. PLoS One. 4, e6037 (2009).
Dempster, A., Laird, N. & Rubin, D. Likelihood from incomplete data via the EM algorithm. J. Royal Stat. Soc. Series B. 39, 1–38 (1977).
Sinnwell, J. P. & Schaid, D. J. haplo.stats: statistical analysis of haplotypes with traits and covariates when linkage phase is ambiguous R package version 1.2.2., (2005).
Hautamaki, R. D., Kobayashi, D. K., Senior, R. M. & Shapiro, S. D. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science. 277, 2002–2004 (1997).
Matsuyama, A., Sakai, N., Ishigami, M., Hiraoka, H., Kashine, S., Hirata, A. et al. Matrix metalloproteinases as novel disease markers in Takayasu arteritis. Circulation. 108, 1469–1473 (2003).
Park, J. A., Shin, K. S. & Kim, Y. W. Polymorphism of matrix metalloproteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease. J Korean Med Sci. 20, 607–611 (2005).
Ikeda, K., Ihara, K., Yamaguchi, K., Muneuchi, J., Ohno, T., Mizuno, Y. et al. Genetic analysis of MMP gene polymorphisms in patients with Kawasaki disease. Pediatr Res. 63, 182–185 (2008).
Acknowledgements
We thank Tamotsu Fujimoto, MD (Pediatrics, Oita Children's Hospital), Joan Pancheri RN, Ellen McGrath RN, Jennifer Foley RN and Jon Goulding, PhD, for DNA collection and DeeAnna Scherrer and Clay Archer for laboratory assistance. We also thank Suzanne Cheng, PhD (Roche Molecular Systems), for helpful discussion. This work was supported in part by grants from the National Institutes of Health and the National Heart, Lung, Blood Institute (HL074864 and HL69413) awarded to JCB.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on Journal of Human Genetics website
Supplementary information
Rights and permissions
About this article
Cite this article
Shimizu, C., Matsubara, T., Onouchi, Y. et al. Matrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with Kawasaki disease. J Hum Genet 55, 779–784 (2010). https://doi.org/10.1038/jhg.2010.109
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/jhg.2010.109
Keywords
This article is cited by
-
Bioinformatic analysis of underlying mechanisms of Kawasaki disease via Weighted Gene Correlation Network Analysis (WGCNA) and the Least Absolute Shrinkage and Selection Operator method (LASSO) regression model
BMC Pediatrics (2023)
-
Identification of novel locus associated with coronary artery aneurysms and validation of loci for susceptibility to Kawasaki disease
European Journal of Human Genetics (2021)
-
Kawasaki disease: pathophysiology and insights from mouse models
Nature Reviews Rheumatology (2020)
-
A Comprehensive Update on Kawasaki Disease Vasculitis and Myocarditis
Current Rheumatology Reports (2020)
-
Inference of human continental origin and admixture proportions using a highly discriminative ancestry informative 41-SNP panel
Investigative Genetics (2013)